Anthem Biosciences Ltd. (ANTHEM): Anthem Biosciences Share Price hits fresh 52-week high at Rs 932.5

Published: 27 August 2026 at 9:29 AM IST

Anthem Biosciences Share Price moved to Rs 932.5 on 27 August 2026, up Rs 9.05 or 0.98% from the previous close of Rs 923.45. The stock also touched a fresh 52-week high of Rs 936 during the session, while market capitalisation stood at Rs 49,292.57 crore. This makes Anthem Biosciences Ltd. (ANTHEM) one of the more closely tracked names in Anthem Biosciences Stock News today, especially for readers following Anthem Biosciences Share Price Today and fresh 52-week high stocks in the Indian stock market.

The session opened at Rs 927.45 and the day’s low was Rs 923.95, while the high matched the yearly high at Rs 936. Turnover stood at Rs 2.42 crore. The data confirms the price event and the new 52-week peak, but it does not establish a company-specific catalyst. For investors scanning Anthem Biosciences Share Price Live updates, the verified facts are the move, the range and the valuation backdrop. Univest is tracking the event as part of its daily Stocks in News coverage and share price news flow.

Anthem Biosciences Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 932.5
Previous Close	Rs 923.45
Today's Change	+Rs 9.05 (+0.98%)
Day Open	Rs 927.45
Fresh 52-Week High	Rs 936
Day Low	Rs 923.95
Turnover	Rs 2.42 crore
Market Capitalisation	Rs 49,292.57 crore

Anthem Biosciences Ltd. (ANTHEM) traded at Rs 932.5. versus the previous close of Rs 923.45, a rise of 0.98%. The stock opened at Rs 927.45, reached Rs 936, touched Rs 923.95.

The day’s setup was straightforward: the stock opened close to the prior close, traded within a relatively tight band and then tested the top of that range. A fresh 52-week high during the session signals that the market was willing to pay up to Rs 936, even though the close settled slightly below that mark. For readers looking at a 52 week high stock screen, that sequence matters because it shows where demand appeared strongest during the day.

Anthem Biosciences Ltd. (ANTHEM) traded at Rs 932.5 versus the previous close of Rs 923.45, a rise of 0.98%. The stock opened at Rs 927.45, reached a high of Rs 936 and touched a low of Rs 923.95.

Anthem Biosciences Share Price Today reflected a narrow but positive session. The stock opened at Rs 927.45, traded between Rs 923.95 and Rs 936, and closed effectively near the upper end of that band at Rs 932.5. The fresh 52-week high of Rs 936 is only Rs 3.50 above the current price, which shows that the stock finished close to its yearly high after touching it intraday. Turnover of Rs 2.42 crore provides the traded-value context for the session without adding any further interpretation. The close also stayed above the opening price, which keeps the session in positive territory from start to finish. In simple terms, the day was not a wide swing; it was a controlled move that still produced a yearly peak. That combination often draws attention in market news flow because it signals price discovery near the top of the recent range. For daily tracking, the important datapoints remain the open, intraday high, low, close and turnover, all of which are verified here. The stock did not need a large absolute gain to set the headline event, as the yearly high itself was the main technical marker. This is the kind of session that places the name on watchlists for investors monitoring momentum, though the data supplied here does not support any forecast.

For readers comparing share price news with broader Market News, the key point is simple: the day’s move was positive, the stock marked a fresh 52-week high, and the session closed just below that level. That is the factual basis behind today’s update and the reason the name entered 52 Week High Stocks screens. Univest uses this same session data to keep the commentary precise and event-led.

Anthem Biosciences Ltd. (ANTHEM) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 49,292.57 crore
P/E Ratio	90.34x
P/B Ratio	16.63x
ROE	21.98%
ROCE	29.62%
EPS	Rs 10.22
Book Value Per Share	Rs 55.55
Dividend Yield	0.22%

Anthem Biosciences Ltd. (ANTHEM) fundamental metrics show P/E 90.34x, P/B 16.63x, ROE 21.98%, ROCE 29.62%. These figures provide context only and are not a buy or sell signal.

Anthem Biosciences Ltd. has a market capitalisation of Rs 49292.57 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 90.34x, P/B at 16.63x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 21.98% and ROCE of 29.62%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 10.22, book value per share of Rs 55.55, dividend yield of 0.22%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.54x, median ROE of 11.83%, median ROCE of 13.75%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	90.34x
Benchmark Median P/E	30.54x
Benchmark Average P/E	46.91x
Benchmark P/E Range	3.19x to 671.51x
Company P/B Ratio	16.63x
Benchmark Median P/B	2.76x
Company ROE	21.98%
Benchmark Median ROE	11.83%
Company ROCE	29.62%
Benchmark Median ROCE	13.75%
Company Market Capitalisation	Rs 49,292.57 crore
Benchmark Median Market Cap	Rs 623.8 crore

Anthem Biosciences Ltd. (ANTHEM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Anthem Biosciences Ltd. (ANTHEM) has a P/E ratio of 90.34x, which is above the benchmark median of 30.54x, a difference of +195.81%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Anthem Biosciences Ltd. (ANTHEM) has a ROE of 21.98%, which is above the benchmark median of 11.83%, a difference of +85.8%. Anthem Biosciences Ltd. (ANTHEM) has a ROCE of 29.62%, which is above the benchmark median of 13.75%, a difference of +115.42%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Ipca Laboratories Ltd.	IPCALAB	48,969.99	37.81	5.84	15.88	19.41
Glaxosmithkline Pharmaceuticals Ltd.	GLAXO	50,483.85	48.02	20.35	48.76	66.79
Gland Pharma Ltd.	GLAND	46,538.74	42.46	4.51	10.56	14.96
Ajanta Pharma Ltd.	AJANTPHARM	44,449.8	39.03	9.12	25.42	32.67
Abbott India Ltd.	ABBOTINDIA	56,173.06	34.88	10.88	34.67	46.72

Anthem Biosciences Ltd. (ANTHEM) has a P/E ratio of 90.34x compared with the displayed peer median of 39.03x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 21.98% compares with a peer median of 25.42% across the companies shown in the table. ROCE stood at 29.62% versus the displayed peer median of 32.67%, providing a capital-efficiency comparison. Anthem Biosciences Ltd. (ANTHEM) has a market capitalisation of Rs 49,292.57 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

Why Investors Are Watching Anthem Biosciences

• Anthem Biosciences Share Price touched a fresh 52-week high of Rs 936 and closed at Rs 932.5.
• The session change was Rs 9.05, equal to 0.98% from the previous close of Rs 923.45.
• Market capitalisation stood at Rs 49,292.57 crore.
• P/E was 90.34, P/B was 16.63, EPS was Rs 10.22 and book value per share was Rs 55.55.
• ROE was 21.98% and ROCE was 29.62% in the supplied fundamentals.

About Anthem Biosciences

Anthem Biosciences Ltd. is classified in Healthcare and the Pharmaceuticals & Drugs industry. In the verified data supplied for this article, the company is referenced through its stock identifier ANTHEM and its market-data profile on NSE and BSE-linked coverage. For readers using Univest, this company overview is best read alongside the same-day share price, the fresh 52-week high event and the disclosed financial ratios. The coverage remains anchored to these supplied facts and avoids unsupported interpretation.

Track Anthem Biosciences Share Price on Univest

Use Anthem Biosciences Ltd. (ANTHEM) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Track Anthem Biosciences Share Price on Univest for live price updates, market cap, 52-week levels, valuation ratios, shareholding pattern, financial ratios and peer context. Univest keeps the stock page structured for quick checks on Anthem Biosciences Share Price Today, Anthem Biosciences Latest News and broad market updates.

Frequently Asked Questions

What is Anthem Biosciences Share Price today?

Ans. Anthem Biosciences Share Price was Rs 932.5, up Rs 9.05 or 0.98% from the previous close of Rs 923.45. The stock also touched a fresh 52-week high of Rs 936 during the session.

Did Anthem Biosciences hit a 52-week high today?

Ans. Yes. Anthem Biosciences touched a fresh 52-week high of Rs 936 on 27 August 2026. The current price closed at Rs 932.5, keeping it close to the day’s peak. The stock moved 0.98% during the session.

What was Anthem Biosciences’ market capitalisation?

Ans. Anthem Biosciences had a market capitalisation of Rs 49,292.57 crore. That places the company well above the industry median market cap in the supplied Healthcare benchmark. The company operates in the Healthcare sector.

What do the valuation ratios show for Anthem Biosciences Share Price?

Ans. The stock carried a P/E of 90.34 and a P/B of 16.63. EPS was Rs 10.22 and book value per share was Rs 55.55, which gives context for the current share price.

How do ROE and ROCE look for Anthem Biosciences?

Ans. Anthem Biosciences reported ROE of 21.98% and ROCE of 29.62%. Both figures sit above the same-industry medians in the supplied Healthcare benchmark and help frame the company’s fundamentals. ROE stands at 21.98%.